Noncontiguous Stage II Grade 3 Follicular Lymphoma Terminated Phase Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0029309 (Noncontiguous Stage II Grade 3 Follicular Lymphoma)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01076270Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment